the obese woman

14
An exploration of problems for the obese woman in Obstetrics and Gynaecology for Primary Care Specialists Epidemiology Science of obesity General disease Gynae cancers Subfertility Pregnancy Contraception Dr Jane Wilcock BSc FRCGP MA H Ed. Year 3 academic curriculum lead University of Liverpool Community clinical tutor General Practitioner Silverdale Medical Practice ( formerly Lowry Medical Practice) Salford.

Upload: janewilcock

Post on 02-Jul-2015

237 views

Category:

Health & Medicine


5 download

DESCRIPTION

This is a look at the physiology of obesity and the effects on the woman in terms of illness.

TRANSCRIPT

Page 1: The obese woman

An exploration of problems for the obese woman in Obstetrics and Gynaecology for Primary Care Specialists

bull Epidemiologybull Science of obesity bull General diseasebull Gynae cancersbull Subfertilitybull Pregnancybull Contraception

Dr Jane WilcockBSc FRCGP MA H EdYear 3 academic curriculum lead University of LiverpoolCommunity clinical tutor General Practitioner Silverdale Medical Practice ( formerly Lowry Medical Practice) Salford

How much has obesity risen in the UK over the past eight years 1993 16 of women were obese2011 26 of women

bull Definitionsbull BMI 25-30 overweightbull BMI 30+ obesebull BMI40+ severely obesebull BMIgt50 extreme obesity

bull Concerns relate to abdominal obesity and so waist sizeWomen 88cm 34ins increases the risk of T2DM x 3

Science of obesity

Relationships between fat GIT ovaries and the brain

are complex uncertain and interesting

Fat increases with age It is related to ethnicity Visceral obesity increases after the menopause

135 genes identified as related to obesity so far

Epigenetics (foetal programming)

Subcutaneous fat doesnrsquot really matter but white fat around the abdomen proliferates sets up inflammation cell death and causes disease

Is obesity a low grade inflammatory process

Interleukins and TNF-alfa are released in obesity

Where does the brain control obesity

Paraventricular nucleus and arcuate nucleus at the hypothalamus control hunger satiety

Ghrelin acts on the hypothalamus to increase appetite increases gastric acid and GIT motilityHigh levels occur before eatingHigh levels in Prader-Willi syndromeLower levels after bariatric surgery BUT not reduced in obesity Ghrelin produced from GITsecreted by an empty stomach

Vagus nerve Reduces appetite

Leptin is secreted by fat cellswhen lipid levels arehigh and regulates fat storesReduces appetiteIncreased levels in obesity BUT patients are Leptin resistant

Fat cells are endocrine organs

SecreteOestrogen

Secrete Leptinto cause satietyBut obesity has high leptin levels but leptinresistance

Secrete Adiponectinwhich regulates fatty acidand glucose metabolismIncreases insulin sensitivityIncreased by pioglitazoneLow levels in obesityRelated to insulin resistance

Thiazolidines (glitazones pioglitazone) modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in muscle fat and

liver

Metabolic syndrome

Lack of confidenceDepressionCVA

CHD

HypertensionDyslipidaemia

Type 2 DMGallstonesCKD in type 2 DMNAFLDNASHcirrhosis

SnoringSleep apnoea

DVTLeg oedema

Life expectancy reduced by 3-10 years inobese people Obesitycontributes to 1 in 13 deaths in Europe

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 2: The obese woman

How much has obesity risen in the UK over the past eight years 1993 16 of women were obese2011 26 of women

bull Definitionsbull BMI 25-30 overweightbull BMI 30+ obesebull BMI40+ severely obesebull BMIgt50 extreme obesity

bull Concerns relate to abdominal obesity and so waist sizeWomen 88cm 34ins increases the risk of T2DM x 3

Science of obesity

Relationships between fat GIT ovaries and the brain

are complex uncertain and interesting

Fat increases with age It is related to ethnicity Visceral obesity increases after the menopause

135 genes identified as related to obesity so far

Epigenetics (foetal programming)

Subcutaneous fat doesnrsquot really matter but white fat around the abdomen proliferates sets up inflammation cell death and causes disease

Is obesity a low grade inflammatory process

Interleukins and TNF-alfa are released in obesity

Where does the brain control obesity

Paraventricular nucleus and arcuate nucleus at the hypothalamus control hunger satiety

Ghrelin acts on the hypothalamus to increase appetite increases gastric acid and GIT motilityHigh levels occur before eatingHigh levels in Prader-Willi syndromeLower levels after bariatric surgery BUT not reduced in obesity Ghrelin produced from GITsecreted by an empty stomach

Vagus nerve Reduces appetite

Leptin is secreted by fat cellswhen lipid levels arehigh and regulates fat storesReduces appetiteIncreased levels in obesity BUT patients are Leptin resistant

Fat cells are endocrine organs

SecreteOestrogen

Secrete Leptinto cause satietyBut obesity has high leptin levels but leptinresistance

Secrete Adiponectinwhich regulates fatty acidand glucose metabolismIncreases insulin sensitivityIncreased by pioglitazoneLow levels in obesityRelated to insulin resistance

Thiazolidines (glitazones pioglitazone) modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in muscle fat and

liver

Metabolic syndrome

Lack of confidenceDepressionCVA

CHD

HypertensionDyslipidaemia

Type 2 DMGallstonesCKD in type 2 DMNAFLDNASHcirrhosis

SnoringSleep apnoea

DVTLeg oedema

Life expectancy reduced by 3-10 years inobese people Obesitycontributes to 1 in 13 deaths in Europe

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 3: The obese woman

Science of obesity

Relationships between fat GIT ovaries and the brain

are complex uncertain and interesting

Fat increases with age It is related to ethnicity Visceral obesity increases after the menopause

135 genes identified as related to obesity so far

Epigenetics (foetal programming)

Subcutaneous fat doesnrsquot really matter but white fat around the abdomen proliferates sets up inflammation cell death and causes disease

Is obesity a low grade inflammatory process

Interleukins and TNF-alfa are released in obesity

Where does the brain control obesity

Paraventricular nucleus and arcuate nucleus at the hypothalamus control hunger satiety

Ghrelin acts on the hypothalamus to increase appetite increases gastric acid and GIT motilityHigh levels occur before eatingHigh levels in Prader-Willi syndromeLower levels after bariatric surgery BUT not reduced in obesity Ghrelin produced from GITsecreted by an empty stomach

Vagus nerve Reduces appetite

Leptin is secreted by fat cellswhen lipid levels arehigh and regulates fat storesReduces appetiteIncreased levels in obesity BUT patients are Leptin resistant

Fat cells are endocrine organs

SecreteOestrogen

Secrete Leptinto cause satietyBut obesity has high leptin levels but leptinresistance

Secrete Adiponectinwhich regulates fatty acidand glucose metabolismIncreases insulin sensitivityIncreased by pioglitazoneLow levels in obesityRelated to insulin resistance

Thiazolidines (glitazones pioglitazone) modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in muscle fat and

liver

Metabolic syndrome

Lack of confidenceDepressionCVA

CHD

HypertensionDyslipidaemia

Type 2 DMGallstonesCKD in type 2 DMNAFLDNASHcirrhosis

SnoringSleep apnoea

DVTLeg oedema

Life expectancy reduced by 3-10 years inobese people Obesitycontributes to 1 in 13 deaths in Europe

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 4: The obese woman

Where does the brain control obesity

Paraventricular nucleus and arcuate nucleus at the hypothalamus control hunger satiety

Ghrelin acts on the hypothalamus to increase appetite increases gastric acid and GIT motilityHigh levels occur before eatingHigh levels in Prader-Willi syndromeLower levels after bariatric surgery BUT not reduced in obesity Ghrelin produced from GITsecreted by an empty stomach

Vagus nerve Reduces appetite

Leptin is secreted by fat cellswhen lipid levels arehigh and regulates fat storesReduces appetiteIncreased levels in obesity BUT patients are Leptin resistant

Fat cells are endocrine organs

SecreteOestrogen

Secrete Leptinto cause satietyBut obesity has high leptin levels but leptinresistance

Secrete Adiponectinwhich regulates fatty acidand glucose metabolismIncreases insulin sensitivityIncreased by pioglitazoneLow levels in obesityRelated to insulin resistance

Thiazolidines (glitazones pioglitazone) modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in muscle fat and

liver

Metabolic syndrome

Lack of confidenceDepressionCVA

CHD

HypertensionDyslipidaemia

Type 2 DMGallstonesCKD in type 2 DMNAFLDNASHcirrhosis

SnoringSleep apnoea

DVTLeg oedema

Life expectancy reduced by 3-10 years inobese people Obesitycontributes to 1 in 13 deaths in Europe

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 5: The obese woman

Fat cells are endocrine organs

SecreteOestrogen

Secrete Leptinto cause satietyBut obesity has high leptin levels but leptinresistance

Secrete Adiponectinwhich regulates fatty acidand glucose metabolismIncreases insulin sensitivityIncreased by pioglitazoneLow levels in obesityRelated to insulin resistance

Thiazolidines (glitazones pioglitazone) modulates the transcription of the insulin-sensitive genes involved in the control of glucose and lipid metabolism in muscle fat and

liver

Metabolic syndrome

Lack of confidenceDepressionCVA

CHD

HypertensionDyslipidaemia

Type 2 DMGallstonesCKD in type 2 DMNAFLDNASHcirrhosis

SnoringSleep apnoea

DVTLeg oedema

Life expectancy reduced by 3-10 years inobese people Obesitycontributes to 1 in 13 deaths in Europe

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 6: The obese woman

Metabolic syndrome

Lack of confidenceDepressionCVA

CHD

HypertensionDyslipidaemia

Type 2 DMGallstonesCKD in type 2 DMNAFLDNASHcirrhosis

SnoringSleep apnoea

DVTLeg oedema

Life expectancy reduced by 3-10 years inobese people Obesitycontributes to 1 in 13 deaths in Europe

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 7: The obese woman

Cancers any age but cancer is age related163 endometrial cancer131 gallbladder cancerKidneyLiverColonCervixThyroid109 Ovary105Postmenopausal breastcancerPancreasRectumLeukaemiaAssociation with increased BMI and adenocarcinomaof the oesophagusin non-smokers pancreas and gastric in non-smokers

Increased BMI reduces risk of premenopausal breast cancer

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 8: The obese woman

bull 2 of thyroid cancer and

30 endometrial cancers in the UK

due to overweight and obese BMIs

bull Risk of endometrial cancer is increased by x 2-3 and

if very obese increased by x 6

bull Physical activity can reduce endometrial cancer risk by 20-30

bull PCOS women have an increased x 4 risk of endometrial cancer pre-menopause related to obesity

50 of obese people do not think that losing weight reduces their risk of cancer

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 9: The obese woman

Maternal deathDVTDMPETSevere haemorrhageLabour inductionShoulder dystociaDelivery by caesarean section General anaesthesia and anaesthetic complications

Early onset obesity is related tooligomenorrhoeamenstrual irregularityanovulation and subfertility

Increased rate of miscarriage

Reduced IVF if BMIgt30women are less likely to come for help with fertility and if BMIgt40 less likely to be accepted for treatment

Ovulatory obese women have an increased rate of subfertility but may have less sex

Male obesity associated with low testosteroneLow LH and FSHReduced spermatogenesisIncreased EDReduced libido

Conception and Pregnancy

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 10: The obese woman

poor perinatal outcomesmacrosomiaincluding stillbirth and neonatal death

Bottom LinesHigher maternal complications and mortalityHigher perinatal complications and mortalityMore difficult to conceive

Measure BMI and waist at bookingRefer for nutritional advice and exercise programmesAsk women to keep BMI 20-25 in pregnancy (Asian women 23)Take folic acid 5mg a dayThink T2DM and BPMay end up on heparin (DVT) and aspirin ( if one other risk

factor for PET and obese)Bariatric surgery Nutritional deficiency and problems donrsquot

conceive for 12 monthsMultidisciplinary teams required

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 11: The obese woman

Contraception

CHC

FRSH consider risks of DVT and hypertension in

Assessing CHC and possibly CHC is less effective

BMIgt35 risk 3 (donrsquot use)

BMI 30-34 probably okay risk2

POP okay

Nexplanon Current Faculty guidance states that women

with a BMI gt 30 can use a progestogen-only implant without restriction and without a reduction in contraceptive efficacy for the duration of the licensed use

Depo-provera increased weight gain than non-obese women but recommended

IUS and Cu-IUCD may be difficult to insert but recommended

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 12: The obese woman

Emergency contraceptions

Copper bearing intrauterine device Cu- IUCD

Ulipristal acetate (UPA) Ella One

Levonorgestrel (LNG)

Nov 2013 ldquoIn clinical trials contraceptive efficacy was reduced in women weighing 75 kg or more and levonorgestrel was not effective in women who weighed more than 80 kgldquo

This has been reversed by FRSH June 2014

ldquoEmergency contraceptives can continue to be used to prevent

unintended pregnancy in women of any weight or body mass index

(BMI) The available data are limited and not robust enough to support

with certainty the conclusion of decreased contraceptive effect with

increased bodyweightBMIrdquo

Obesity is not a contraindication to any of these methods

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 13: The obese woman

Summary

bull The obese woman attending the GP or Nurse should be thought of holistically not just BP and CHD risk

bull Risks re conception pregnancy outcomes and cancer are not widely known and discussed

bull There is a whole skill set to develop in discussing these issues

Thankyou

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk

Page 14: The obese woman

bull Articles used in this slide set

ndash httpwwwnhsuknews201302FebruaryPagesLatest-obesity-stats-for-England-are-alarming-readingaspx NHS Choices

ndash Annals of the New York Academy of Sciences 2012 Obesity and cancer risk evidence mechanisms and recommendations by Vucenik et al

ndash wwwnhsuknew20307JulyDoes genetic fat mutation cause obesityndash wwwcancerresearchukobesityndash Obesity and infertility by Pasquali R Patton L Gamineri A Curr Opin Endcrinol

Diabetes Obes 2007 Dec 14(6) 482-7 wwwncbinimnihgovpubmedndash Obesity and male infertility Ahmad O Hammond et al Obesity and Male Infertility

Semin Reprod Med 2012 30(6) 468-495ndash Nature July 2014 Neuroscience Dissecting appetite Bijal P Trivedi Nature 508 S64ndashS65

(17 April 2014) Published online 16 April 2014 Obes Rev 2007 Jan8(1)21-34 The role of leptin and ghrelin in the regulation of food intake and body weight in humans a review Klok MD1 Jakobsdottir S Drent ML

ndash Obes Rev 2005 Feb6(1)13-21 Adiponectin action regulation and association to insulin sensitivity Lihn AS1 Pedersen SB Richelsen B

ndash Obesity and Reproductive Health- study group statement RCOG clinical guideance on line accessed 0814 at wwwrcoguk

ndash First Nordic Conference on Obesity 9n Gynaecology and Obstetrics Jorgensen JS et al May 2013 Acta Obstetrica et Gynaecologica Scandinavia 93 pp 982-987

ndash Slide illustration templates Grace at magicsheepiehotmailcouk